×
ADVERTISEMENT

FEBRUARY 1, 2017

ASH MM Roundup by Saad Usmani, MD

Progress in Newly Diagnosed and Relapsed MM Settings

img-button
Saad Z. Usmani, MD
Director of Clinical Research (Hematologic Malignancies),
Director of Plasma Cell Disorders
Levine Cancer Institute/?Carolinas HealthCare System


Charlotte, North Carolina

The 2016 annual meeting of the American Society of Hematology proved to be a very fascinating meeting for both multiple myeloma (MM) investigators and clinicians, with promising data presented on patients with both early and later stages of disease. The following is a review of some of the important MM